FDA Panel Backs Pfizer’s Low-Dose COVID-19 Vaccine for Kids

COVID-19 illustration by the Centers for Disease Control and Prevention.

WASHINGTON (AP) — U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for young children.

The vote Tuesday by the Food and Drug Administration panel moves the nation closer to vaccinating children ages 5 to 11.

The FDA isn’t bound by the recommendation and is expected to make its own decision within days.

If regulators agree, shots could begin as early as late next week.

Young kids would get just a third of the dose given to teens and adults.

A study found kid-size vaccinations are nearly 91% effective at preventing symptomatic infections.

By LAURAN NEERGAARD and MATTHEW PERRONE, The Associated Press
About Grady Culhane

Grady Culhane is a Cape Cod native currently living in Eastham. He studied media communications at Cape Cod Community College and joined the CapeCod.com News Center in 2019.



CapeCod.com
737 West Main Street
Hyannis, MA 02601
Contact Us | Advertise Terms of Use 
Employment and EEO | Privacy